Search research articles
Contact Us
Filters
Showing results (361-370 of 376) with videos related to
Page
of 38
Sort By:
Frontiers in Cell and Developmental Biology
|
September 19, 2022
The PTPIP51 coiled-coil domain is important in VAPB binding, formation of ER-mitochondria contacts and IP3 receptor delivery of Ca<sup>2+</sup> to mitochondria
Gábor M Mórotz, Sandra M Martín-Guerrero, Andrea Markovinovic, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association
|
January 1, 1973
1,25-dihydroxycholecalciferol in patients with chronic renal failure
R G Henderson, J G Ledingham, A W Norman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 6, 1999
Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro
J E Fisher, M J Rogers, J M Halasy, et al.
Acta Endocrinologica
|
December 1, 1982
Long-term treatment of osteoporosis with 24,25 dihydroxycholecalciferol
J Reeve, M Tellez, J R Green, et al.
Clinical Endocrinology
|
December 1, 1977
Correlation of clinical, biochemical and skeletal responses to 1alpha-hydroxyvitamin D3 in renal bone disease
J A Kanis, M Earnshaw, R G Henderson, et al.
Lancet (London, England)
|
June 29, 1985
Intravenous clodronate in the treatment and retreatment of Paget's disease of bone
A J Yates, R C Percival, R E Gray, et al.
Msphere
|
September 10, 2020
Phosphorylation of <i>Toxoplasma gondii</i> Secreted Proteins during Acute and Chronic Stages of Infection
Joanna C Young, Malgorzata Broncel, Helena Teague, et al.
QJM : Monthly Journal of the Association of Physicians
|
May 14, 1998
Management of male osteoporosis: report of the UK Consensus Group
R Eastell, I T Boyle, J Compston, et al.
QJM : Monthly Journal of the Association of Physicians
|
November 13, 2001
Secondary prevention of osteoporosis: when should a non-vertebral fracture be a trigger for action?
R Eastell, D M Reid, J Compston, et al.
The Journal of Clinical Investigation
|
February 23, 2016
Lymphatic endothelial cells are a replicative niche for Mycobacterium tuberculosis
Thomas R Lerner, Cristiane de Souza Carvalho-Wodarz, Urska Repnik, et al.
Page
of 38
Search research articles
Search
Showing results (361-370 of 376) with videos related to
Sort By:
Page
of 38
Frontiers in Cell and Developmental Biology
|
September 19, 2022
The PTPIP51 coiled-coil domain is important in VAPB binding, formation of ER-mitochondria contacts and IP3 receptor delivery of Ca<sup>2+</sup> to mitochondria
Gábor M Mórotz, Sandra M Martín-Guerrero, Andrea Markovinovic, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association
|
January 1, 1973
1,25-dihydroxycholecalciferol in patients with chronic renal failure
R G Henderson, J G Ledingham, A W Norman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 6, 1999
Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro
J E Fisher, M J Rogers, J M Halasy, et al.
Acta Endocrinologica
|
December 1, 1982
Long-term treatment of osteoporosis with 24,25 dihydroxycholecalciferol
J Reeve, M Tellez, J R Green, et al.
Clinical Endocrinology
|
December 1, 1977
Correlation of clinical, biochemical and skeletal responses to 1alpha-hydroxyvitamin D3 in renal bone disease
J A Kanis, M Earnshaw, R G Henderson, et al.
Lancet (London, England)
|
June 29, 1985
Intravenous clodronate in the treatment and retreatment of Paget's disease of bone
A J Yates, R C Percival, R E Gray, et al.
Msphere
|
September 10, 2020
Phosphorylation of <i>Toxoplasma gondii</i> Secreted Proteins during Acute and Chronic Stages of Infection
Joanna C Young, Malgorzata Broncel, Helena Teague, et al.
QJM : Monthly Journal of the Association of Physicians
|
May 14, 1998
Management of male osteoporosis: report of the UK Consensus Group
R Eastell, I T Boyle, J Compston, et al.
QJM : Monthly Journal of the Association of Physicians
|
November 13, 2001
Secondary prevention of osteoporosis: when should a non-vertebral fracture be a trigger for action?
R Eastell, D M Reid, J Compston, et al.
The Journal of Clinical Investigation
|
February 23, 2016
Lymphatic endothelial cells are a replicative niche for Mycobacterium tuberculosis
Thomas R Lerner, Cristiane de Souza Carvalho-Wodarz, Urska Repnik, et al.
Page
of 38